These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12938718)

  • 1. The concepts of critical organ and radiation dose as applied to plutonium.
    Stannard JN
    Health Phys; 2003 Sep; 85(3):264-73; discussion 273-4. PubMed ID: 12938718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two case studies of highly insoluble plutonium inhalation with implications for bioassay.
    Carbaugh EH; La Bone TR
    Radiat Prot Dosimetry; 2003; 105(1-4):133-8. PubMed ID: 14526943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the ICRP's dose coefficients for members of the public. III. Plutonium as a case study of uncertainties in the systemic biokinetics of radionuclides.
    Leggett RW
    Radiat Prot Dosimetry; 2003; 106(2):103-20. PubMed ID: 14653331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk estimates for deterministic health effects of inhaled weapons grade plutonium.
    Scott BR; Peterson VL
    Health Phys; 2003 Sep; 85(3):280-93. PubMed ID: 12938719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: regional tissue doses for 239PuO2 and 238UO2/238U3O8.
    Farfán EB; Huston TE; Bolch WE; Vernetson WG; Bolch WE
    Health Phys; 2003 Apr; 84(4):436-50. PubMed ID: 12705442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plutonium content of human placental tissues after occupational exposure.
    Russell JJ; Sikov MR; Kathren RL
    Radiat Prot Dosimetry; 2003; 104(3):231-6. PubMed ID: 14565729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of state of health on organ distribution and excretion of systemic plutonium in the Mayak workers.
    Suslova KG; Khokhryakov VF; Tokarskaya ZB; Nifatov AP; Sokolova AB; Kudryavtzeva TI; Miller SC; Krahenbuhl MP
    Radiat Prot Dosimetry; 2003; 105(1-4):229-33. PubMed ID: 14526961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of Bayesian techniques in the interpretation of bioassay data.
    Miller G; Little T; Guilmette R
    Radiat Prot Dosimetry; 2003; 105(1-4):333-8. PubMed ID: 14526981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative role of plutonium excretion with urine and feces from human body.
    Khokhryakov VF; Suslova KG; Kudryavtseva TI; Schadilov AE; Vostrotin VV; Lagounova NY; Barabanshchikova AY
    Health Phys; 2004 May; 86(5):523-7. PubMed ID: 15083148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying the ICRP 66 dosimetry model based on results obtained from Mayak plutonium workers.
    Romanov SA; Guilmette RA; Hahn FF; Nifatov AP; Zaytseva YV; Lyovkina YV
    Radiat Prot Dosimetry; 2003; 105(1-4):85-90. PubMed ID: 14526933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of ICRP metabolic models for the transuranics in a Japanese population.
    Hisamatsu S; Takizawa Y
    Health Phys; 2003 Dec; 85(6):701-8. PubMed ID: 14626321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of intakes of mixtures of radionuclides.
    O'Brien RS
    Radiat Prot Dosimetry; 2003; 105(1-4):95-100. PubMed ID: 14526935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: a parameter sensitivity analysis.
    Huston TE; Farfán EB; Bolch WE; Bolch WE
    Health Phys; 2003 Nov; 85(5):553-66. PubMed ID: 14571988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro dissolution study of plutonium in aerosol particles from the Mayak PA: a tool for individualised dose estimates.
    Aladova EE; Romanov SA; Guilmette RA; Khokhryakov VF; Suslova KG
    Radiat Prot Dosimetry; 2007; 127(1-4):60-3. PubMed ID: 17704503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plutonium microdistribution in the lungs of Mayak workers.
    Hahn FF; Romanov SA; Guilmette RA; Nifatov AP; Diel JH; Zaytseva Y
    Radiat Res; 2004 May; 161(5):568-81. PubMed ID: 15161366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of Dose, Risk, and Compensation Assessments for US Veterans of the 1966 Plutonium Cleanup in Palomares, Spain.
    Beyea J; von Hippel FN
    Health Phys; 2019 Dec; 117(6):625-636. PubMed ID: 31283545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical action levels for chelation therapy in plutonium inhalation using nose swab.
    Kurihara O; Takada C; Takasaki K; Ito K; Momose T; Miyabe K
    Radiat Prot Dosimetry; 2007; 127(1-4):411-4. PubMed ID: 17567761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plutonium--health implications in man. The concepts of critical organ and radiation dose as applied to plutonium.
    Stannard JN
    Health Phys; 1975 Oct; 29(4):539-50. PubMed ID: 1205857
    [No Abstract]   [Full Text] [Related]  

  • 20. A computational study of the urinary excretion rates for 339Pu using new ICRP internal dosimetry models.
    Singh IS; Sharma RC; Abani MC
    Radiat Prot Dosimetry; 2003; 105(1-4):361-4. PubMed ID: 14526987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.